STOCK TITAN

Institutional holders disclose 11.7% in National Research Corp (NRC)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

National Research Corp received an amended Schedule 13G/A reporting significant institutional ownership of its ordinary shares (CUSIP 637372202) as of December 31, 2025. Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 2,657,832 shares, representing 11.7% of the class. It has sole voting power over 458,587 shares and shared voting power over 2,176,636 shares, with similar levels of dispositive power.

Virtus Investment Advisers, LLC reports beneficial ownership of 1,739,966 shares, or 7.7% of the class, all with shared voting and dispositive power. Virtus Equity Trust on behalf of Virtus KAR Small-Cap Growth Fund reports 1,708,009 shares, or 7.5%, also entirely with shared voting and dispositive power. The filers certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of National Research Corp.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: The amounts reported on this page are also included in the amounts reported by Kayne Anderson Rudnick Investment Management, LLC on this Schedule 13G


SCHEDULE 13G




Comment for Type of Reporting Person: The amounts reported on this page are also included in the amounts reported by Virtus Investment Advisers, LLC on this Schedule 13G.


SCHEDULE 13G



Kayne Anderson Rudnick Investment Management, LLC
Signature:/s/Michael Shoemaker
Name/Title:Chief Compliance Officer
Date:02/13/2026
Virtus Investment Advisers, LLC
Signature:/s/Chetram Persaud
Name/Title:Chief Compliance Officer
Date:02/13/2026
Virtus Equity Trust on behalf of Virtus KAR Small-Cap Growth Fund
Signature:/s/Daphne Chisolm
Name/Title:Vice President, Counsel and Assistant Secretary
Date:02/13/2026

FAQ

What does this Schedule 13G/A filing report for NRC?

The filing reports significant institutional ownership of National Research Corp ordinary shares. Kayne Anderson Rudnick, Virtus Investment Advisers, and a Virtus fund disclose sizable stakes and related voting and dispositive powers, while certifying the shares are held in the ordinary course of business, not to influence control.

How many National Research Corp shares does Kayne Anderson Rudnick hold?

Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 2,657,832 National Research Corp ordinary shares, representing 11.7% of the class. It has sole voting power over 458,587 shares and shared voting power over 2,176,636 shares, with similar sole and shared dispositive authority levels.

What stake in NRC is reported by Virtus Investment Advisers, LLC?

Virtus Investment Advisers, LLC reports beneficial ownership of 1,739,966 National Research Corp shares, equal to 7.7% of the class. All of these shares are reported with shared voting and shared dispositive power, and the amounts are also included in the totals reported by Kayne Anderson Rudnick.

What ownership does Virtus KAR Small-Cap Growth Fund report in NRC?

Virtus Equity Trust on behalf of Virtus KAR Small-Cap Growth Fund reports beneficial ownership of 1,708,009 National Research Corp shares, or 7.5% of the class. All shares are held with shared voting and shared dispositive power, and the amounts are also included in the figures for Virtus Investment Advisers, LLC.

Do the reporting persons intend to influence control of National Research Corp?

The reporting persons state the securities were acquired and are held in the ordinary course of business. They certify the holdings were not acquired and are not held to change or influence control of National Research Corp, other than activities solely in connection with a nomination under Rule 240.14a-11.

Who signed the NRC Schedule 13G/A on behalf of the reporting entities?

The filing is signed by compliance and legal officers of the reporting entities. Signatories include Michael Shoemaker and Chetram Persaud, each as Chief Compliance Officer, and Daphne Chisolm as Vice President, Counsel and Assistant Secretary, certifying the accuracy and completeness of the information provided.
National Resh Corp

NASDAQ:NRC

NRC Rankings

NRC Latest News

NRC Latest SEC Filings

NRC Stock Data

273.46M
11.57M
46.42%
51.54%
1.62%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States
LINCOLN